BioWorld

Aug. 20, 2002

View Archived Issues

Saegis Nearing End Of Phase II While Still Using Series A Cash

As the baby boomers age, many will face problems with memory they used to associate with their parents and grandparents. (BioWorld Today) Read More

Tragen Seeks Funding, Partners For Phase II Cancer Compound

Read More

Anti-Angiogenic Drug, VEGF-Trap By Name, Most Potent Ever Seen,' Scores In Preclinical Mouse Tests

Read More

Shares Of OSI, ImClone Take Hit On AstraZeneca Results

Read More

Other News To Note

Read More